• Orca Bio Raises $192 Million Series D to Transform Allogenic Cell Therapy 


    • Forty Seven Agrees to Sell to Gilead for $4.9 Billion  


    • TiVo and Xperi to Combine in $3 Billion All-Stock Merger 


    • Oportun Financial – $108 Million IPO  


    • Fastly – $207 Million IPO 


    • Forty Seven – $113 Million IPO